Hemostasis And Tissue Sealing Agents Market: By Product(Topical Hemostat, Adhesive & Tissue Sealant) By Type (Titanium, Steel, Others) By Application (Minimally Invasive Surgery, General Surgery) End-User (Hospitals, Ambulatory Centers) Regional Analysis & Forecast - 2026
- OI-153 |
- Published date: Jul, 2019 |
- Medical Devices |
- 120 Pages
Market Overview
Hemostasis and Tissue Sealing Agents are an important part of the management of bleeding within the damaged blood vessels in surgical procedures. This is mainly used in medicine that includes chronic conditions to control excessive bleeding, ophthalmic injuries or replacements, burns, neurosurgeries, urological disorder, hernia fixation surgery, orthopedic surgery, and spinal injury. These agents permit rapid hemostasis, better Visualization of the surgical area, decreased the requirement for transfusions, decreased wound healing time shorter operative times, and an overall improvement in patient recovery time.
The Global Hemostasis and Tissue Sealing Agents Market was valued at $ 2.12 bn in 2018 and is forecasted to grow at a strong 9.21% CAGR between 2018 and 2026, resulting in 2026 global sales of $ 4.29. Market-driven by growing demand for faster recovery by patients and increasing number surgical procedures are some of the components boosting the market. However, strict regulatory policies coupled with the high cost of the products and risk of complications are some of the components hampering the growth of the market. Moreover, investing in emerging economies provides a good platform for companies to record high revenue will provide lucrative opportunities for the market.
Hemostasis and Tissue Sealing Agents Market depending on the product, adhesives, and sealants segment is dominated due to controlling blood loss during surgeries and it functions by binding with and sealing the harmed tissues. Binding leads to the advancement of a hindrance over the injuries & surgical wound and advances coagulation. The aspects helping their demand over sutures are a minimal invasion, quicker procedure rate, reduced post-surgical infections, and anticipation of exudation of other body fluids.
Key Developments
- On 9th April 2019, Baxter International has received the U.S. Food and Drug Administration (FDA) approval for faster preparation of its leading hemostatic product, Floseal Hemostatic Matrix. This next generation of Floseal has 20 percent fewer components and steps to prepare, making it a faster and convenient for usage.
Segmentation
The Global Hemostasis and Tissue Sealing Agents Market are segmented based on the product, type, application, end-user, and regions.
Based on the Product: Topical Hemostat and Adhesive & tissue sealant
Based on the Type: Titanium, Steel, Stainless Steel, Composite Material, Nickel Material, and Zirconium
Based on the Application: Minimally Invasive Surgery and General Surgery
Based on the End User: Hospitals and Ambulatory Centers
Based on the Region: North America, Asia-Pacific, Europe, and LAMEA. Among that Asia Pacific region is projected to witness high growth during the forecast period due to rapid growth in the surgery volume brought about by the introduction of medical tourism emerging economies such as India, China and Singapore and this countries with presence of relatively more developed healthcare infrastructure, advanced treatments, and large pool of patients.
The key players of the Global Hemostasis and Tissue Sealing Agents Market include Becton, Dickinson and Company, B. Braun Melsungen AG, Ethicon Inc, Medtronic plc, Smith & Nephew plc, Stryker Corporation, Zimmer Biomet, Z-Medica LLC, Advanced Medical Solutions Group plc, Pfizer, Baxter, etc..
Report Description: The report covers an in-depth analysis of the Global Hemostasis and Tissue Sealing Agents Market. The report assesses the market products pipeline by-product (Topical Hemostat and Adhesive & tissue sealant), by type (Titanium, Steel, Stainless Steel, Composite Material, Nickel Material, and Zirconium), by application (Minimally Invasive Surgery and General Surgery) by end-user (Hospitals and Ambulatory Centers). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.
The report includes in-depth company profiles of key players in the Global Hemostasis and Tissue Sealing Agents Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments.
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.
Scope:
- Provides detailed analysis of the market structure along with forecast of the various segments and sub-segments of the Global Hemostasis and Tissue Sealing Agents Market
- Provides a comparative analysis of key marketed and pipeline products
- Provides key information on players involved in the Global Hemostasis and Tissue Sealing Agents Market
- Provides a complete overview of market segments and the regional outlook of Global Hemostasis and Tissue Sealing Agents Market
Provides in-depth coverage of key news related to Global Hemostasis and Tissue Sealing Agents Market, including major mergers and acquisitions and product development updates such as clinical trial progression updates and regulatory updates
-
Data Collation (Primary & Secondary)
-
In-house Estimation (Based on proprietary databases and Models)
-
Market Triangulation
-
Forecasting
-
Market-related information is assembled from both primary and secondary sources.
-
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
-
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
-
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.
